New York, NY 6 Jan 2020:
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is
anticipated to reach USD 2.63 billion by 2025. Impotence, also known as
erectile dysfunction is the condition of sexual dysfunction where, during the
sexual intercourse, men cannot maintain the erection. According to World Health
Organization statement, for the emotional, physical and wellbeing of the
individual, and to the economic and social development of countries and
communities, sexual health is a fundamental thing. Erectile dysfunction affects
the quality of life for both partners and patients and is connected with
relationship difficulties.
Erectile dysfunction is generally an age-related condition
but can also be triggered by psychological factors. Cardiovascular diseases
such as high blood pressure, clogged arteries etc., diabetes, hormonal
insufficiency, chronic kidney disease, multiple sclerosis, injury to the penis,
bladder, and pelvis, and neurological issues are the common factor which can
cause erectile dysfunction. Moreover, sedentary lifestyle, smoking, excessive
alcohol intake, obesity and consumption of drugs such as, antihypertensive
drugs, antidepressant, recreational drugs, and psychotropic drugs are some
other factors which are significantly contributing towards erectile dysfunction.
Exercise, pharmacotherapy, well balanced and maintain lifestyle, penis
implants, erection devices, and injections into penis are current treatment
available to cure erectile dysfunction. Currently, oral PDE5 (phosphodiesterase
type 5 inhibitors) is the first line drug therapy prescribed by physicians for
erectile dysfunction.
Request for a sample of this research report: https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/request-for-sample
The availability of oral drugs globally, and rising awareness
about erectile dysfunction and sexual diseases is resulting in significant
adoption of treatment globally. Moreover, rising number of referrals to
secondary care and primary care consultations is expected to propel the growth
of erectile dysfunctions drugs market over the forecast period. The increasing
elderly population and high rate of chronic diseases such as kidney failure,
diabetes, hypertension, hormonal imbalance, and neurological disorders are
increasing demand for erectile dysfunction drugs globally.
The global erectile
dysfunction drugs market is segmented on the basis of drug type, dosage form,
end user, and geographically. On the basis of drug type, the global erectile
dysfunction market is further segmented into Testosterone, Phosphodiestarse – 5
Inhibitors (PDE5I), Alprostadil, and others. Testosterone is hormone. The lack
of testosterone hormone cause impotence or erectile dysfunction, and in such
conditions, testosterone hormones are prescribed to the patient to balance the
hormone in the body. The Phosphodiestarse – 5 Inhibitors is the drug used to
control or block the degenerative action of c-GMP specific phosphodiesterase
type 5 (PDE5) on cyclic GMP. The Sildenafil, Vardenafil, Tadalafil, Avanafil,
Udenafil are the few examples of Phosphodiestarse – 5 Inhibitors. The
Phosphodiestarse – 5 Inhibitors drugs are most commonly prescribed drugs to
treat erectile dysfunction and hence accounted major share in global erectile
dysfunction drugs market.
Have Questions? make an Inquiry before buying this
report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/request-for-sample
The high effectiveness and efficacy of Phosphodiestarse – 5
Inhibitors are the major factors contributing towards the large share in the
global erectile dysfunction market. The introduction of long effective pills
such as Levitra (vardenafil) and Cialis (tadalafil) are effective for 36 hours
and hence they are also know as weekend pill. Moreover, the increasing research
and development and various drugs for erectile dysfunction are in various
stages of pipeline. The introduction of such blockbuster drugs in the market
over the forecast period is expected to propel the growth of erectile
dysfunction market globally.
By dosage form, the global erectile dysfunction drugs market
is further sub segmented into topical, oral, injections and others. The oral
segment accounted major share in global erectile dysfunction drugs market. The
oral drugs are more convenient to handle the dose, and hence it is highly
preferable dosage form. The injections segment is expected to grow at high CAGR
over the forecast period.
About Polaris Market
Research
Polaris Market Research is a
global market research and consulting company. The company specializes in
providing exceptional market intelligence and in-depth business research
services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email:
sales@polarismarketresearch.com
Web:
www.polarismarketresearch.com
